Spots Global Cancer Trial Database for SIR-Spheres® 90Y Microspheres Treatment of Uveal Melanoma Metastasized to Liver
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: SIR-Spheres® 90Y Microspheres Treatment of Uveal Melanoma Metastasized to Liver
Official Title: An Open-Label, Single Institution, Phase II Study Using Radioactive Yttrium90 Microsphere (SIR-Sphere®) in Uveal Melanoma Patients With Hepatic Metastasis
Study ID: NCT01473004
Conditions
Interventions
Study Description
Brief Summary: The purpose of this study is to determine whether radiation provided locally to the liver tumor vasculature environment will demonstrate a response of tumor decline. This radiation may cause the tumor cells to die.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Thomas Jefferson University, Philadelphia, Pennsylvania, United States
Contact Details
Name: Takami Sato, MD
Affiliation: Thomas Jefferson University
Role: PRINCIPAL_INVESTIGATOR
Name: Carin Gonsalves, MD
Affiliation: Thomas Jefferson University
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
